CYMABAY THERAPEUTICS INC (CBAY)
Institutional ownership reported to the SEC as of Q1 2024, across 22 quarters.
1
Reporting holders
$21.1K
Reported value
0.0%
Held as options
-190
Holder change
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
| Filer | Value | Shares | Their book | Held | Change |
|---|---|---|---|---|---|
| IFP Advisors, Inc | $21.1K | 650 | 0.00% | 15q | HELD |
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q1 2024 | 1 | $21.1K | 650 | 0 | 0 | 0 | 0.0% |
| Q4 2023 | 191 | $2.7B | 109,378,362 | 29 | 71 | 56 | 3.8% |
| Q3 2023 | 179 | $1.6B | 105,421,119 | 63 | 51 | 49 | 4.0% |
| Q2 2023 | 142 | $1.0B | 92,218,377 | 42 | 38 | 36 | 0.3% |
| Q1 2023 | 127 | $716.4M | 81,190,367 | 37 | 40 | 33 | 1.2% |
| Q4 2022 | 104 | $346.2M | 55,442,678 | 27 | 24 | 20 | 1.1% |
| Q3 2022 | 98 | $219.3M | 62,285,760 | 11 | 19 | 30 | 0.6% |
| Q2 2022 | 103 | $187.1M | 63,016,648 | 18 | 30 | 33 | 0.6% |
| Q1 2022 | 110 | $204.9M | 65,464,971 | 17 | 36 | 25 | 0.6% |
| Q4 2021 | 114 | $220.2M | 63,916,494 | 18 | 38 | 23 | 1.9% |
| Q3 2021 | 113 | $173.5M | 46,379,316 | 17 | 21 | 38 | 2.4% |
| Q2 2021 | 110 | $233.0M | 52,159,676 | 10 | 26 | 41 | 2.4% |
| Q1 2021 | 129 | $256.5M | 55,438,320 | 19 | 42 | 34 | 1.9% |
| Q4 2020 | 143 | $332.8M | 56,534,831 | 39 | 41 | 33 | 2.5% |
| Q3 2020 | 120 | $432.7M | 59,104,448 | 27 | 28 | 41 | 1.1% |
| Q2 2020 | 115 | $212.8M | 59,905,163 | 39 | 31 | 33 | 1.8% |
| Q1 2020 | 104 | $89.6M | 58,658,383 | 18 | 28 | 30 | 1.1% |
| Q4 2019 | 113 | $116.9M | 59,162,238 | 27 | 32 | 27 | 0.8% |
| Q3 2019 | 137 | $333.8M | 64,100,209 | 21 | 41 | 36 | 1.7% |
| Q2 2019 | 133 | $501.6M | 67,832,930 | 23 | 54 | 29 | 3.2% |
| Q1 2019 | 145 | $919.7M | 69,071,569 | 26 | 47 | 34 | 0.3% |
| Q4 2018 | 131 | $463.9M | 58,855,240 | 3 | 2 | 4 | 0.2% |